Parsity Group

The battle between biosimilars and originator companies is heating up, with rebate strategies taking centre stage. Discover how this tactic impacts healthcare costs and access to biosimilars. Key points from the article:  🔹Rebate wars: How originator companies are leveraging rebates to maintain market dominance.  🔹Impact on costs: The implications of these strategies on healthcare spending.  🔹Challenges for biosimilars: How these tactics hinder biosimilar adoption.  🔹Future outlook: What this means for patients, providers, and policymakers. Read more here: https://lnkd.in/esnzM33s #biopharma #biosimilars #competition #us #healthcare

Happy Thanksgiving! This Thanksgiving, we at Parsity Group want to express our gratitude to all our candidates, clients, and partners. Your trust and collaboration have been key to our success, and we’re truly thankful for the opportunity to work alongside such inspiring professionals. Whether you're celebrating with family, friends, or colleagues, we wish you a day full of joy, connection, and reflection. From all of us at Parsity Group, Happy Thanksgiving! #Thanksgiving #Gratitude #ParsityGroup #US #Thanks

US Election: What’s Next for Biosimilars and Generics? Our latest blog impartially examines what a Trump presidency might mean for the generics and biosimilars market, exploring potential opportunities and challenges. Opportunities:  💠Faster FDA approvals  💠Incentives for domestic manufacturing  💠Increased market competition   Challenges:  💠Uncertainty around drug pricing reforms  💠Potential trade disruptions  💠Shifts in healthcare policy This is a must-read for anyone in pharma, healthcare, or policy who wants to stay ahead of the curve. Discover actionable strategies for navigating these changes and thriving in a dynamic policy landscape. Click here to read the full blog https://lnkd.in/e8Pkqgk8 #US #healthcare #election #generics #biosimilars

Biopharma Industry Sees Major Milestone in Contract Manufacturing Recent developments underscore the expanding role of contract development and manufacturing organisations (CDMOs) in the global biopharma landscape. The rising demand for outsourcing in biologics and biosimilars reflects the industry’s evolution toward more collaborative and specialised drug development and manufacturing approaches. The continued growth of CDMOs may reshape how pharmaceutical companies bring innovative therapies to market, impacting accessibility and affordability worldwide. Read more here https://lnkd.in/ehXRj8WW #Biopharma #CDMO #Generics #Biosimilars #PharmaTrends

AI in Executive Search: Enhancing Human Expertise AI is transforming the executive search industry, but its role is to enhance—not replace—human expertise. By streamlining workflows, providing actionable insights, and improving time efficiencies, AI empowers professionals to focus on what truly matters: building relationships and making intuitive, informed decisions. Key highlights:  💠AI delivers real-time market data for sharper strategies.  💠Automates repetitive tasks, freeing time for personal interactions.  💠Enhances processes, while human intuition ensures cultural and leadership fit. Discover how technology and humanity combine for better leadership hiring. Read the full blog https://lnkd.in/e_2Xv_Rk #leadership #AI #Future #chatgpt #executivesearch

At Parsity Group, we’re here to help whether you’re actively hiring or just exploring the talent landscape. If you’re not quite ready to make an executive hire, we’re happy to provide expert advice on any current or future projects. Here’s how we can support you:  💠Compensation & Benefits: Craft competitive packages.  💠Refining Hiring Processes: Prepare for success.  💠Market Mapping: Explore potential candidates and market insights.  💠Interview Techniques: Enhance your approach.  💠Psychometric Testing: Make informed decisions.  💠DE&I Strategies: Build inclusive teams. Let’s start a conversation—no brief required. For more information about our services visit our website: https://lnkd.in/etxjqQxD #executiveSearch #partnership #advice #consult #insights

A New Generic Pill to Help Smokers Quit The NHS has launched a generic anti-smoking drug, bringing fresh hope to those battling nicotine addiction. Here's why this is a significant step forward: 💠Cost-effective innovation: As a generic drug, it offers affordability alongside effectiveness. 💠Impact potential: Set to help thousands quit smoking, improving public health outcomes. 💠Global precedence: Highlights how generics play a pivotal role in increasing access to life-changing medications. Find out more about how this breakthrough is shaping public health: Read the full article. https://lnkd.in/exuRRpAm #NHS #Healthcare #Medicine #Generics

Boosting Financial Performance Through DE&I in Pharma Explore how embracing Diversity, Equity, and Inclusion (DE&I) fuels success in the pharmaceutical industry, particularly for C-suite executives. Key points: 🔹 Diversity Drives Profitability: Top-quartile diverse companies often outpace competitors by up to 36%. 🔹 Innovation & Problem Solving: Diverse teams bring new ideas and solutions, essential in pharma. 🔹 Enhanced Decision-Making: Varied perspectives reduce blind spots in high-stakes decisions. 🔹 Talent Attraction & Retention: Inclusive cultures attract and keep top talent. Read more on building a high-impact DE&I strategy to boost financial performance. https://lnkd.in/eh4J7hpp #leadership #diversity #profit #pharma #executivesearch 

At Parsity Group, we are proud to be a modern forward-thinking executive search firm that blends cutting-edge technology with personal expertise. Our approach ensures we prioritise authentic client and candidate interactions, while using technology to enhance—not replace—our services. Efficiency Through AI: ●       We leverage AI for administrative tasks like meeting notes and maintaining CRM systems, enhancing productivity and accuracy. ●       This allows our team to focus on personalised, meaningful engagements with clients and candidates. Our Commitment to Personal Touch: ●       Unlike some firms, we do not use AI for the search process itself or to communicate with clients or candidates. Every interaction is led by experienced consultants who understand the nuances of the generics and biosimilars industry. ●       This human-centric approach ensures that relationships remain strong, trust is built, and quality is upheld throughout the hiring process. Why It Matters: ●       Technology frees up our team to dedicate more time to understanding your unique needs and tailoring solutions that align with your company culture. ●       It also means candidates receive the thoughtful, personal attention they deserve during the recruitment journey. With Parsity Group, you get the best of both worlds: the speed and efficiency of AI-enhanced operations combined with the deep industry insight and personal touch of seasoned search professionals.   For more information about our services visit our website: https://lnkd.in/etxjqQxD #executivesearch #parnership #AI #agility #technology    

Biosimilars & Generics: Game-Changing Savings Did you know that biosimilars and generics contributed an impressive $445 billion in U.S. healthcare savings in 2023? These cost-effective solutions are reshaping access to medicine, providing affordable treatment options and driving industry-wide efficiencies. Key Statistics: 💠Total generic and biosimilar savings in 2023: $445 billion 💠Total generic and biosimilar savings for the past 10 years: $3.1 trillion 💠Total generic and biosimilar savings in Medicare in 2023: $137 billion ($2,672 per beneficiary) 💠 Total generic and biosimilar savings in the commercial market in 2023: $206 billion 💠 Share of total U.S. prescriptions filled: 90% 💠 Share of total U.S. prescription drug spending: 13.1% 💠 Share of total U.S. healthcare spending: 1.2% Discover the full impact of these figures and what they mean for the future of healthcare here. https://lnkd.in/eN8Df-9T #US #generics #biosimilars #healthcare #pharma